Periode bali modal bisnis Assertio (ASRT)
Assertio Holdings, Inc. (ASRT) manages a diverse portfolio of neurological medications through its US representatives, leveraging the promotion of proven pain relief treatments. The business model is based on physician loyalty and strict DEA oversight of opioids. Growth is driven by mergers with niche brands and partnerships with suppliers. This price chart demonstrates the value of -4.30, visualizing the company's current earnings multiple.
Rincian analitis perusahaan Assertio Holdings (ASRT)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- data kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Rasio Kabeh Utang marang Dana Pribadi Assertio Holdings, Inc.|ASRT - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Assertio Therapeutics|ASRT - Gunggung utang perusahaan|Utang-utang marang aset resik Assertio Holdings, Inc.|ASRT - Utang jangka dawa perusahaan|Utang jangka cendhak Assertio|Rasio jangkoan perantara assertiotx.com
- rincian bathi lan kelipatan pasar:
ASRT - Bathi resik|Penghasilan resik sing dikarepake Assertio Holdings, Inc.|ASRT - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Assertio Therapeutics|ASRT - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Assertio Holdings, Inc.|ASRT - Bathi operasional EBITDA|Bathi saben saham sajrone 12 wulan pungkasan Assertio|ASRT - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan assertiotx.com|ASRT - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Assertio Holdings, Inc.
- statistik dodolan lan pendapatan perusahaan:
Ringkesan analisis perusahaan:Assertio Holdings, Inc.
The analyst evaluates the credit profile of Assertio Holdings, Inc. (ASRT) by comparing the business's market value with its net income, which allows for the determination of the investment payback period via the P/E ratio history. Amid pressure from cheap generics and high marketing costs, this indicator reveals the risk of overpaying for the asset, helping to distinguish a favorable entry point from a dangerous decline in fundamental value.
Analisis perusahaan pesaing
Pangali P/E biogen.com|Rasio rega marang bathi Neurocrine Biosciences, Inc. (NBIX)|Periode bali modal bisnis Regencell Bioscience Ltd|Rasio rega marang bathi Axsome Therapeutics Inc AXSM|Periode bali modal bisnis ACADIA Corp (ACAD)|Xenon Pharmaceuticals - Pangali P/E|Kapitalisasi marang bathi vikingtherapeutics.com|Supernus (SUPN) - Rasio rega marang bathi|Catalyst Pharma - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi DNLI|HRMY (Harmony Corp) - Rasio rega pasar marang bathi resik|Pangali P/E BHVN|Periode bali modal bisnis amylyx.com|Rasio rega marang bathi Trevi Therapeutics, Inc. TRVI|Praxis Precision Medicines Inc (PRAX) - Kapitalisasi marang bathi|AVXL: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik CBLL (CeriBell EEG)|PRTA: Pangali P/E|Alector - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Annexon|Kapitalisasi marang bathi Omeros Corp. OMER|Rasio rega marang bathi Neurogene Corp (NGNE)|Rasio rega marang bathi ACIU (AC Immune Inc)|Pangali P/E VYGR (Voyager Therapeutics)|NMRA: Pangali rega marang bathi|Scilex - Pangali P/E|Periode bali modal bisnis Tevogen Bio Holdings Inc. TVGN|alphacognition.com (ACOG) - Rasio rega marang bathi|Pangali rega marang bathi CGTX|IKT (Inhibikase Therapeutics) - Pangali P/E|SAVA - Rasio kapitalisasi marang bathi resik|Rasio rega marang bathi Coya Therapeutics, Inc. (COYA)|Periode bali modal bisnis vistagen.com|Ovid Therapeutics - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik ABOS|CervoMed Inc. - Pangali P/E|Periode bali modal bisnis Alterity Therapeutics ATHE|clene.com (CLNN) - Rasio rega marang bathi|Pangali rega marang bathi PEPG|JUNS (Jupiter Neurosciences) - Pangali P/E|Koefisien rega marang bathi Relmada Corp (RLMD)|Koefisien rega marang bathi ANVS (Annovis Bio, Inc.)|Periode bali modal bisnis gracetx.com|Pangali P/E AIFF (Firefly Neuroscience)|Pangali P/E ANEW Medical KLTO|NRSN - Rasio rega marang bathi|Periode bali modal bisnis Reviva Pharmaceuticals, Inc. RVPH|metaviatx.com (MTVA) - Rasio rega marang bathi|neuraxis.com - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HSDT|PASG (Passage Bio Corp) - Rasio rega pasar marang bathi resik|Rasio rega marang bathi Neuphoria Therapeutics Inc. (NEUP)|Minerva - Pangali rega marang bathi|Pangali P/E ATHA (Athira Pharma, Inc.)|addextherapeutics.com (ADXN) - Kapitalisasi marang bathi|ALZN: Koefisien rega marang bathi|CYCN - Pangali P/E|protagenic.com (PTIX) - Rasio rega marang bathi|Pasithea Therapeutics Corp. - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Cortigent Inc|Kapitalisasi marang bathi avenuetx.com ATXI|Pangali P/E BCLI|Pangali P/E Cara Therapeutics Inc. (CARA)|Rasio rega marang bathi Chromocell Therapeutics Corporation CHRO|Periode bali modal bisnis Eliem Therapeutics, Inc. (ELYM)|ITCI - Rasio rega marang bathi|Periode bali modal bisnis longboardpharma.com LBPH|MRNS: Pangali P/E|Kapitalisasi marang bathi NKGen Biotech Inc (NKGN)|Rasio rega marang bathi NeuroBo|SAGE: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SNPX (Synaptogenix, Inc.)|Rasio rega pasar marang bathi resik TRVN|Pangali P/E VIGL (Vigil Neuroscience, Inc.)|Periode bali modal bisnis anewmeds.com (WENA)|CERE - Rasio rega marang bathi
